Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 44 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2012Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceWu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M.
2012Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsGelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.
2014Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaMulholland, C.; Somogyi, A.; Barratt, D.; Coller, J.; Hutchinson, M.; Jacobson, G.; Cursons, R.; Sleigh, J.
1999Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4Coller, J.; Somogyi, A.; Bochner, F.
1998Quantification of flunitrazepam's oxidative metabolites, 3-hydroxyflunitrazepam and desmethylflunitrazepam, in hepatic microsomal incubations by high performance liquid chromatography.Coller, J.; Somogyi, A.; Bochner, F.
2014Pharmacogenomics of methadone maintenance treatmentSomogyi, A.; Barratt, D.; Ali, R.; Coller, J.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2008Response to "No influence of ABCB1 haplotypes on methadone dosage requirement"Coller, J.; Barratt, D.; Somogyi, A.